AdipoPharma SAS is developing a therapeutic peptide, PATAS, that targets adipocyte cells to restore healthy lipid biosynthesis and reduce harmful lipids like ceramides, which contribute to insulin resistance and type 2 diabetes. This approach aims to improve metabolic health by addressing the underlying lipid management issues associated with these conditions, with clinical trials set to begin in 2025.

Alunacare provides a cloud‑based platform that lets clinicians create and deliver customizable digital health questionnaires, symptom trackers, and wearable data integrations to patients’ devices. The system aggregates responses in real time, applies analytics to highlight trends and alerts, and presents the data through a secure, HIPAA‑compliant dashboard that can be embedded into existing EHR workflows, helping outpatient clinics and health systems monitor treatment effectiveness and detect early warning signs remotely.

Angiocrine Bioscience provides a GMP‑compliant cell‑therapy platform that engineers endothelial and stromal cells to secrete angiocrine growth factors for tissue regeneration. The E‑CEL Therapies platform delivers autologous and allogeneic cell products targeting vascular remodeling and extracellular matrix repair across cardiac, hepatic, and musculoskeletal indications. It serves pharmaceutical, biotech, and academic partners developing regenerative treatment candidates.

AOA Dx is developing GlycoLocate™, a multi-omics platform that utilizes tumor marker gangliosides for early-stage cancer detection, specifically through the AKRIVIS GD™ liquid biopsy test for ovarian cancer. This technology offers high sensitivity and specificity, addressing the critical need for effective early diagnosis in women's health.

Aralez Bio utilizes engineered enzymes to produce noncanonical amino acids, which are essential building blocks for peptide drugs, in a sustainable and cost-effective manner. This approach significantly reduces manufacturing time and costs, addressing the challenges of traditional amino acid production that often leads to long lead times and supply chain uncertainties.

Ateios provides the RaiCure™ platform, a radiation‑curable polymer coating that replaces thermal curing and toxic solvents in battery electrode manufacturing. The drop‑in solution enables thicker, higher‑density electrodes, cuts energy use by up to 82%, and speeds production up to five times while reducing capital and operating costs and eliminating PFAs.

Avisi Technologies is developing VisiPlate, a nanotechnology-enabled aqueous shunt designed to lower intraocular pressure in patients with open-angle glaucoma. This investigational implant addresses the risk of irreversible blindness by providing a minimally invasive solution that enhances aqueous drainage through a network of microchannels.

Base Operations develops a threat intelligence platform that utilizes natural language processing and AI to analyze over 150 million incidents from more than 20,000 data sources, providing granular insights into crime and unrest at the street level. This technology enables organizations to proactively assess risks and enhance security planning by identifying patterns and trends before incidents occur.

Blue Ocean Gear provides sensored tracking buoys that utilize satellite and radio communication to deliver real-time GPS data on the location and movement of fishing gear. This technology enables commercial fishermen to quickly locate their gear, identify issues early, and optimize their fishing operations.

Boston Materials provides a drop‑in thermal interface material, Liquid Metal ZRT®, that combines a carbon‑fiber scaffold with a liquid‑metal filler to deliver anisotropic heat conduction for high‑power GPUs and ASICs. The TIM reduces device junction temperatures by 5–8 °C on 1 kW+ workloads, enabling higher power limits and lower cooling energy, and is compatible with existing server and liquid‑cooling designs.

Boston Scientific designs and manufactures FDA‑cleared medical devices that enable minimally invasive procedures across specialties such as cardiology, electrophysiology, urology, gastroenterology, and neurology. Its portfolio—including catheters, stents, implantable sensors, and drug‑eluting platforms—integrates advanced materials, imaging, and navigation technologies to improve procedural accuracy, reduce complications, and shorten patient recovery. The company also supports clinicians with clinical data, training programs, and 24/7 technical service to streamline adoption and maintain device performance.

Bounce Imaging provides lightweight, throwable 360° tactical cameras that deliver real‑time omnidirectional video and two‑way audio to any iOS or Android device via Wi‑Fi or 4G/LTE. Designed for first‑responders, law‑enforcement, and military teams, the rugged devices can be tossed, lowered on a tether, or mounted on a pole to quickly visualize confined or hazardous spaces, improving situational awareness and officer safety.

This company develops compact terahertz imagers for real-time, proactive concealed weapons detection. Their systems use adaptive AI to interpret high-resolution terahertz data, accurately identifying metallic and non-metallic threats as people move naturally. These discreet imagers integrate with existing surveillance or operate as standalone units to enhance security awareness.

Coagulo Medical Technologies has created a portable precision-medicine platform that employs connected diagnostic tools for real-time blood coagulation monitoring. This technology provides immediate and accurate assessments of coagulation status in patients, which is critical for informed treatment decisions in emergency care.

CoapTech has developed the PUMA-G System, the first FDA-cleared ultrasound-based solution for bedside gastrostomy tube placement, which enhances patient safety by visualizing tissue layers to prevent organ damage and infections. This technology significantly reduces hospital costs and lengths of stay, achieving an average savings of $26,621 per patient compared to traditional PEG procedures.

The startup has developed a nanostructured oleophilic and hydrophobic sponge that effectively absorbs oil and repels water, enabling the removal of pollutants and toxins from contaminated water sources. This recyclable sponge provides a practical solution for businesses and communities to mitigate environmental contamination from industrial runoff.

This company develops and provides bioscience solutions focused on animal health and sustainable food production. They offer USDA-approved vaccines for honeybees to protect against major diseases and are developing vaccines for shrimp to combat White Spot Syndrome Virus. Their technology leverages natural immune defenses to deliver targeted disease protection across agricultural sectors.

Databento offers a cloud‑based market data platform that provides both historical and real‑time full order‑book streams via a single API, with pay‑as‑you‑go pricing that charges only for consumed data. The service includes multi‑language SDKs and handles data onboarding, normalization, and delivery, allowing quantitative firms and fintech developers to integrate high‑resolution market data into trading, research, and analytics pipelines without managing complex feed infrastructure.

Dynepic offers a cloud‑native platform that centralizes the ingestion, version control, and spatial tagging of 3D models, point clouds, and holographic scenes for AR, VR, and MR applications. The service provides low‑code authoring, Unity and Unreal SDKs, automated multi‑format transcoding with edge CDN distribution, and enterprise‑grade access control and analytics for scalable immersive knowledge delivery.

Eden utilizes Electrical Reservoir Stimulation technology to enhance subsurface permeability by breaking rocks with electricity, significantly improving the recovery of natural resources. This method reduces water consumption by billions of gallons compared to traditional fracturing techniques, addressing the need for sustainable resource extraction.

Encora Therapeutics is developing a wearable device that utilizes real-time signal processing to deliver personalized vibro-tactile stimulation to the wrist, effectively counteracting hand tremors associated with neurodegenerative movement disorders like Parkinson's disease. This non-invasive technology not only alleviates tremors but also enables continuous monitoring of disease progression for improved patient care.

Fermata Discovery develops VIXN, an integrated intelligence platform that utilizes graph technology to analyze and manage intelligence and OSINT data for investigators. This solution enhances the efficiency of investigative workflows by revealing hidden relationships and streamlining collaboration among analysts and detectives.

Fisherman is a platform that automates the creation and management of websites for independent restaurants, enabling them to establish an online presence with minimal effort and no technical expertise. By streamlining the setup process and providing ongoing support, Fisherman helps restaurants increase customer engagement and drive sales through a user-friendly, branded website launched in under a week.

Fluree is an open-source semantic graph database that utilizes distributed ledger technology to ensure data integrity and traceability while embedding programmable security policies for real-time governance. It enables enterprises to manage trusted data for AI applications, ensuring compliance with privacy regulations and reducing errors in data sharing.